- Home
- ATYR vs GDEV Comparison
ATYR vs GDEV Comparison
Compare ATYR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATYR | GDEV |
|---|---|---|
| Founded | 2005 | 2009 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 388.5M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATYR | GDEV |
|---|---|---|
| Price | $0.78 | $16.64 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 6.7K |
| Earning Date | 11-06-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.98 |
| EPS | N/A | ★ 3.08 |
| Revenue | $190,000.00 | ★ $412,018,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,728.88 | $4.89 |
| P/E Ratio | ★ N/A | $5.40 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $8.60 |
| 52 Week High | $7.29 | $42.20 |
Technical Indicators
Market Signals| Indicator | ATYR | GDEV |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 41.95 |
| Support Level | $0.70 | $16.16 |
| Resistance Level | $0.83 | $19.51 |
| Average True Range (ATR) | 0.06 | 2.00 |
| MACD | 0.03 | -0.22 |
| Stochastic Oscillator | 57.87 | 5.41 |
Price Performance
Historical ComparisonAbout ATYR aTyr Pharma Inc.
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.